
The World Health Organization (WHO) is calling for stricter measures to be implemented against tobacco consumption. Rüdiger Krech, the WHO Director of Health Promotion, expressed dissatisfaction with the German government's approach to fighting tobacco use, labeling Germany as a cause for concern. Krech stated, "We cannot really understand why the political measures for tobacco control in Germany are so lax."
In contrast, the WHO reported progress globally on Monday, with more countries taking action against smoking. The new report on the tobacco epidemic states that 5.6 billion people now live in countries that have implemented at least one of the WHO's recommended measures for protecting non-smokers. These measures include graphic warnings on cigarette packages, advertising bans, public smoking bans, and high taxation on tobacco products. The most widely implemented anti-tobacco measure worldwide is the use of graphic images on packaging, which is now regulated in 103 countries with a total population of 4.5 billion.
However, the WHO believes that Germany is lacking several elements in its tobacco control efforts. Krech emphasized that recent cigarette price increases have been below the inflation rate, making smoking ultimately cheaper, not more expensive. The smoking ban in restaurants is patchy, and the advertising ban is implemented inadequately.
The WHO also has reservations about e-cigarettes, stating on its website that "E-cigarettes do not contain tobacco but are harmful to health and are not safe." However, it is still too early to provide a definitive answer on the long-term effects of their use.
Previously, only two countries, Brazil and Turkey, had the highest standards for a tobacco-free world. However, in the latest report, the WHO announced that Mauritius and the Netherlands have also achieved these standards.
On a brighter note, the iconic HB-Männchen character, famous for its tantrums in cigarette advertisements during the economic miracle period of the 1960s, has long since disappeared from screens and billboards. Similarly, the Marlboro Man can no longer promote Camel cigarettes as a "doctor's recommendation.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.




